Detroit, Michigan 48202


This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.


Inclusion Criteria: - DSM-5 diagnosis of insomnia Exclusion Criteria: - acute or unstable medical disease, - current or past history of psychiatric disease, alcoholism or drug abuse, and other primary sleep disorders



Primary Contact:

Principal Investigator
Timothy A Roehrs, PhD
Henry Ford Health System Sleep Disorders Ctr

Gail Koshorek, BS
Phone: 313-916-5179

Backup Contact:


Location Contact:

Detroit, Michigan 48202
United States

Gail Koshorek, BS
Phone: 313-916-5179

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.